MDA-7 (Interleukin-24) inhibits the proliferation of renal carcinoma cells and interacts with free radicals to promote cell death and loss of reproductive capacity

Molecular Cancer Therapeutics

Volumn 2, Issue 7, 2003, Pages 623-632

  Yacoub, Adly ^a   Mitchell, Clint ^a   Brannon, Jessica ^a   Rosenberg, Elizabeth ^a   Qiao, Liang ^a   McKinstry, Robert ^a   Linehan, W Marston ^c   Su, Zao Shong ^d   Sarkar, Devanand ^d   Lebedeva, Irina V ^d   Valerie, Kristoffer ^a   Gopalkrishnan, Rahul V ^d   Grant, Steven ^b   Fisher, Paul B ^d   Dent, Paul ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ARSENIC TRIOXIDE; BCL2L1 PROTEIN, HUMAN; CASPASE; FREE RADICAL; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 24; INTERLEUKIN DERIVATIVE; INTERLEUKIN-24; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; ORGANOARSENIC DERIVATIVE; OXIDE; PROTEIN BCL 2; PROTEIN BCL X; SCAVENGER; VIRUS RECEPTOR;

ADENOVIRUS; APOPTOSIS; ARTICLE; BRAIN TUMOR; CELL CULTURE; CELL DIVISION; COMPARATIVE STUDY; DRUG EFFECT; GENETICS; GLIOMA; HUMAN; KIDNEY; KIDNEY CARCINOMA; KIDNEY TUMOR; METABOLISM; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ACETYLCYSTEINE; ADENOVIRIDAE; ADJUVANTS, IMMUNOLOGIC; APOPTOSIS; ARSENICALS; BCL-X PROTEIN; BRAIN NEOPLASMS; CARCINOMA, RENAL CELL; CASPASES; CELL DIVISION; FREE RADICAL SCAVENGERS; FREE RADICALS; GENES, TUMOR SUPPRESSOR; GLIOMA; GLUTATHIONE TRANSFERASE; HUMANS; INTERLEUKINS; KIDNEY; KIDNEY NEOPLASMS; OXIDES; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, VIRUS; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED;

EID: 1642417725     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Godley, P. A., and Taylor, M. Renal cell carcinoma. Curr. Opin. Oncol., 13: 199-203, 2001. (Pubitemid 32433978)
2. Vogelzang N. J., and Stadler W. M. Kidney cancer. Lancet, 352: 1691-1696, 1998. (Pubitemid 28526138)
3. Motzer, R. J., Bander, N. H., and Nanus, D. M. Renal-cell carcinoma. N. Engl. J. Med., 335: 865-875, 1996.
4. Glaspy, J. A. Therapeutic options in the management of renal cell carcinoma. Semin. Oncol., 29: 41-46, 2002. (Pubitemid 34620435)
5. Milowsky, M. I., and Nanus, D. M. Advanced renal cell carcinoma. Curr. Treat. Options Oncol., 2: 437-445, 2001.
6. Ponnazhagan, S., Curiel, D. T., Shaw, D. R., Alvarez, R. D., and Siegal, G. P. Adeno-associated virus for cancer gene therapy. Cancer Res., 61: 6313-6321, 2001. (Pubitemid 32783229)
7. Gomez-Navarro, J., and Curiel, D. T. Conditionally replicative adenoviral vectors for cancer gene therapy. Lancet Oncol., 1: 148-158, 2000.
8. Curiel, D. T. Strategies to adapt adenoviral vectors for targeted delivery. Ann. N. Y. Acad. Sci., 886: 158-171, 1999. (Pubitemid 30042431)
9. Haviv, Y. S., Blackwell, J. L., Kanerva, A., Nagi, P., Krasnykh, V., Dmitriev, I., Wang, M., Naito, S., Lei, X., Hemminki, A., Carey, D., and Curiel, D. T. Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors. Cancer Res., 62: 4273-4281, 2002. (Pubitemid 34827282)
10. Rauen, K. A., Sudilovsky, D., Le, J. L., Chew, K. L., Hann, B., Weinberg, V., Schmitt, L. D., and McCormick, F. Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy. Cancer Res., 62: 3812-3818, 2002. (Pubitemid 34728866)
11. Okegawa, T., Pong, R. C., Li, Y., Bergelson, J. M., Sagalowsky, A. I., and Hsieh, J. T. The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure. Cancer Res., 61: 6592-6600, 2001. (Pubitemid 32783269)
12. Sauane, M., Gopalkrishnan, R. V., Sarkar, D., Su, Z. Z., Lebedeva, I. V., Dent, P., Pestka, S., and Fisher, P. B. MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev., 14: 35-51, 2003. (Pubitemid 36098430)
13. Sarkar, D., Su, Z. Z., Lebedeva, I. V., Sauane, M., Gopalkrishnan, R. V., Dent, P., and Fisher, P. B. mda-7 (IL-24): signaling and functional roles. Biotechniques, 10: 30-39, 2002.
14. Jiang, H., Lin, J. J., Su, Z. Z., Goldstein, N. I., and Fisher, P. B. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene, 11: 2477-2486, 1995. (Pubitemid 26023815)
15. Parrish-Novak, J., Xu, W., Brender, T., Yao, L., Jones, C., West, J., Brandt, C., Jelinek, L., Madden, K., McKernan, P. A., Foster, D. C., Jaspers, S., and Chandrasekher, Y. A. Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J. Biol. Chem., 277: 47517-47523, 2002. (Pubitemid 36159270)
16. Wang, M., Tan, Z., Zhang, R., Kotenko, S. V., and Liang, P. Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J. Biol. Chem., 277: 7341-7347, 2002. (Pubitemid 34953129)
17. Ekmekcioglu, S., Ellerhorst, J., Mhashilkar, A. M., Sahin, A. A., Read, C. M., Prieto, V. G., Chada, S., and Grimm, E. A. Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas. Int. J. Cancer, 94: 54-59, 2001. (Pubitemid 32801752)
18. Saeki, T., Mhashilkar, A., Chada, S., Branch, C., Roth, J. A., and Ramesh, R. Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro. Gene Ther., 7: 2051-2057, 2000. (Pubitemid 32036772)
19. Jiang, H., Su, Z-z., Lin, J. J., Goldstein, N. I., Young, C. S. H., and Fisher, P. B. The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc. Natl. Acad. Sci. USA, 93: 9160-9165, 1996.
20. Su, Z-z., Lebedeva, I. V., Sarkar, D., Gopalkrishnan, R. V., Sauane, M., Sigmon, C., Yacoub, A., Valerie, K., Dent, P., and Fisher, P. B. Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner. Oncogene, 22: 1164-1180, 2003. (Pubitemid 36363380)
21. Su, Z-z., Lebedeva, I. V., Gopalkrishnan, R. V., Goldstein, N. I., Stein, C. A., Reed, J. C., Dent, P., and Fisher, P. B. A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells. Proc. Natl. Acad. Sci. USA, 98: 10332-10337, 2001. (Pubitemid 32803020)
22. Lebedeva, I. V., Su, Z-z., Chang, Y., Kitada, S., Reed, J. C., and Fisher, P. B. The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Oncogene, 21: 708-718, 2002. (Pubitemid 34146283)
23. Su, Z-z., Madireddi, M. T., Lin, J. J., Young, C. S., Kitada, S., Reed, J. C., Goldstein, N. I., and Fisher, P. B. The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc. Natl. Acad. Sci. USA, 95: 14400-14405, 1998. (Pubitemid 28549379)
24. Madireddi, M. T., Su, Z-z., Young, C. S. H., Goldstein, N. I., and Fisher. P. B. Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy. Adv. Exptl. Med. Biol., 465: 239-261, 2000.
25. Mhashilkar, A. B., Schrock, R. D., Hindi, M., Liao, J., Sieger, K., Kourouma, F., Zou-Yang, X. H., Onishi, E., Takh, O., Vedvick, T. S., Fanger, G., Stewart, L., Watson, G. J., Snary, D., Fisher, P. B., Saeki, T., Roth, J. A., Ramesh, R., and Chada, S. Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy. Mol. Med., 7: 271-282, 2001.
26. Gupta, S., Stravitz, R. T., Dent, P., and Hylemon, P. B. Down-regulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway. J. Biol. Chem., 276: 15816-15822, 2001.
27. Qiao, L., Studer, E., Leach, K., McKinstry, R., Gupta, S., Decker, R., Kukreja, R., Valerie, K., Nagarkatti, P., El Deiry, W., Molkentin, J., Schmidt- Ullrich, R., Fisher, P. B., Grant, S., Hylemon, P. B., and Dent, P. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. Mol. Biol. Cell, 12: 2629-2645, 2001. (Pubitemid 33051930)
28. Dai, Y., Landowski, T. H., Rosen, S. T., Dent, P., and Grant, S. Combined treatment with the checkpoint abrogator UCN-01 and MEK1/2 inhibitors potently induces apoptosis in drug-sensitive and -resistant myeloma cells through an IL-6-independent mechanism. Blood, 100: 3333-3343, 2002. (Pubitemid 35217085)
29. Yu, C., Wang, Z., Dent, P., and Grant, S. MEK1/2 inhibitors promote Ara-C-induced apoptosis but not loss of Deltapsi(m) in HL-60 cells. Biochem. Biophys. Res. Commun., 286: 1011-1018, 2001. (Pubitemid 32924872)
30. McKinstry, R., Qiao, L., Yacoub, A., Dai, Y., Decker, R., Holt, S., Hagan, M. P., Grant, S., and Dent, P. Inhibitors of MEK1/2 interact with UCN-01 to induce apoptosis and reduce colony formation in mammary and prostate carcinoma cells. Cancer Biol. Ther., 1: 243-253, 2002.
31. Miller, W. H., Jr., Schipper, H. M., Lee, J. S., Singer, J., and Waxman, S. Mechanisms of action of arsenic trioxide. Cancer Res., 62: 3893-3903, 2002. (Pubitemid 34792653)
32. Grad, J. M., Bahlis, N. J., Reis, I., Oshiro, M. M., Dalton, W. S., and Boise, L. H. Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells. Blood, 98: 805-813, 2001.
33. Kawabe, S., Nishikawa, T., Munshi, A., Roth, J. A., Chada, S., and Meyn, R. E. Adenovirus-mediated mda-7 gene expression radiosensitizes non-small cell lung cancer cells via TP53-independent mechanisms. Mol. Ther., 6: 637-644, 2002. (Pubitemid 35363696)
34. Liu, Y., Nishikawa, T., Vorburger, S. A., Meyn, R. E., Swisher, S. G., Chada, S., Mirza, N., and Hunt, K. K. Adenoviral-mediated expression of the MDA-7 gene sensitizes breast carcinoma cells to ionizing radiation. Proc. Am. Assoc. Cancer Res., 62: 3209, 2002.
35. Yacoub, A., Mitchell, C., Lister, A., Lebedeva, I. V., Sarkar, D., Su, Z-z., Sigmon, C., McKinstry, R., Qiao, L., Broaddus, W. C., Gopalkrishnan, R., Grant, S., Fisher, P. B., and Dent, P. MDA-7 (IL-24) inhibits the growth and enhances the radiosensitivity of glioma cells in vitro and in vivo. Clin. Cancer Res., in press, 2003.
36. Sarkar, D., Su, Z. Z., Lebedeva, I. V., Sauane, M., Gopalkrishnan, R. V., Valerie, K., Dent, P., and Fisher, P. B. mda-7 (IL-24) mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc. Natl. Acad. Sci. USA, 99: 10054-10059, 2002. (Pubitemid 34831171)
37. Gulli, L. F., Palmer, K. C., Chen, Y. Q., and Reddy, K. B. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity. Cell Growth Differ., 7: 173-178, 1996. (Pubitemid 26049825)
38. Dumoutier, L., Leemans, C., Lejeune, D., Kotenko, S. V., and Renauld, J. C. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J. Immunol., 167: 3545-3549, 2001. (Pubitemid 32910793)
39. Iwama, K., Nakajo, S., Aiuchi, T., and Nakaya, K. Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide. Int. J. Cancer, 92: 518-526, 2001. (Pubitemid 32319425)
40. Miller, W. H., Jr. Molecular targets of arsenic trioxide in malignant cells. Oncologist, 7: 14-19, 2002.
41. Barchowsky, A., Klei, L. R., Dudek, E. J., Swartz, H. M., and James, P. E. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radic. Biol. Med., 27: 1405-1412, 1999. (Pubitemid 30001503)
42. Hyun Park, W., Hee Cho, Y., Won Jung, C., Oh Park, J., Kim, K., Hyuck Im, Y., Lee, M. H., Ki Kang, W., and Park, K. Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis. Biochem. Biophys. Res. Commun., 300: 230-235, 2003. (Pubitemid 36042957)
43. Barchowsky, A., Roussel, R. R., Klei, L. R., James, P. E., Ganju, N., Smith, K. R., and Dudek, E. J. Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways. Toxicol. Appl. Pharmacol., 159: 65-75, 1999. (Pubitemid 29404762)
44. Halicka, H. D., Smolewski, P., Darzynkiewicz, Z., Dai, W., and Traganos, F. Arsenic trioxide arrests cells early in mitosis leading to apoptosis. Cell Cycle, 1: 201-209, 2002.
45. Pestka, S., Kotenko, S. V., and Fisher, P. B. IL-24. In: H. L. Henry and A. W. Norman (eds.), Encyclopedia of Hormones Academic Press, in press, 2003.
46. Dewey, W. C., Ling, C. C., and Meyn, R. E. Radiation-induced apoptosis: relevance to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 33: 781-796, 1995.